| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2019 | AMRN Amarin Corp Plc\uk | Ketchum Steven B | Chief Scientific Officer | Sell | 9,541 | $18.67 | $178,106.62 | -2.6% | |
| Apr 30, 2019 | AMRN Amarin Corp Plc\uk | Kennedy Joseph T | General Counsel | Sell | 27,230 | $18.69 | $508,838.84 | -46.6% | |
| Apr 29, 2019 | LNTH Lantheus Holdings, Inc. | Orlandi Cesare | Chief Medical Officer | Sell | 11,250 | $24.85 | $279,616.50 | -14.1% | |
| Apr 29, 2019 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | See Remarks | Sell | 6,908 | $24.84 | $171,615.44 | -4.3% | |
| Apr 29, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 58,821 | $0.96 | $56,234.48 | - | |
| Apr 26, 2019 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 29,813 | $24.86 | $741,073.67 | -4.4% | |
| Apr 26, 2019 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 701,800 | $1.03 | $722,854.00 | -7.9% | |
| Apr 25, 2019 | CPIX Cumberland Pharmaceuticals Inc | Jacobs Joey A | Director | Buy | 3,708 | $6.15 | $22,789.83 | +0.5% | |
| Apr 24, 2019 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 51,057 | $1.02 | $52,162.71 | -0.4% | |
| Apr 23, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 5,000 | $24.07 | $120,368.00 | -5.4% | |
| Apr 22, 2019 | ELAN Elanco Animal Health Inc | Harrington Michael J | Director | Buy | 3,500 | $26.75 | $93,607.50 | +125.8% | |
| Apr 17, 2019 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $1.63 | $40,750.00 | +5.2% | |
| Apr 16, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 5,000 | $25.26 | $126,297.50 | -5.1% | |
| Apr 16, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 9,478 | $20.67 | $195,878.98 | -5.6% | |
| Apr 16, 2019 | YCBD Cbdmd, Inc. | Sterling Erik | 10% Owner | Sell | 1,057,667 | $4.00 | $4,230,668.00 | -100% | |
| Apr 15, 2019 | ZTS Zoetis Inc. | Lewis Clinton A. Jr.46 | Executive Vice President | Sell | 6,124 | $101.60 | $622,198.40 | -11.2% | |
| Apr 15, 2019 | TLRY Tilray Brands, Inc. | Castaneda Mark | CFO, Secretary, Treasurer | Sell | 10,000 | $51.72 | $517,200.00 | -54.9% | |
| Apr 15, 2019 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 25,000 | $15.09 | $377,365.68 | -5.8% | |
| Apr 15, 2019 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 117,140 | $1.05 | $122,683.42 | -0.8% | |
| Apr 12, 2019 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 15,799 | $25.40 | $401,316.72 | -2.3% | |
| Apr 12, 2019 | LLY Eli Lilly & Co | Zulueta Alfonso G | SVP &President, Lilly Int'l | Sell | 10,000 | $124.65 | $1,246,500.00 | -14.7% | |
| Apr 12, 2019 | LLY Eli Lilly & Co | Barnes Melissa S | Chief Eth/ Cmpl Ofcr &SVP, Erm | Sell | 4,735 | $125.15 | $592,585.25 | -17.7% | |
| Apr 10, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Obus Nelson | Director | Buy | 30,000 | $10.33 | $309,900.00 | +1.1% | |
| Apr 10, 2019 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 200,746 | $1.07 | $214,247.11 | -1.3% | |
| Apr 9, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Obus Nelson | Director | Buy | 30,000 | $10.33 | $310,000.00 | +0.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.